Exosome for mRNA delivery: strategies and therapeutic applications

Z Iqbal, K Rehman, A Mahmood, M Shabbir… - Journal of …, 2024 - Springer
Messenger RNA (mRNA) has emerged as a promising therapeutic molecule with numerous
clinical applications in treating central nervous system disorders, tumors, COVID-19, and …

[HTML][HTML] Mesenchymal stem cell-derived exosomes as drug delivery vehicles in disease therapy

W Zhao, K Li, L Li, R Wang, Y Lei, H Yang… - International Journal of …, 2024 - mdpi.com
Exosomes are small vesicles containing proteins, nucleic acids, and biological lipids, which
are responsible for intercellular communication. Studies have shown that exosomes can be …

Encapsulation and assessment of therapeutic cargo in engineered exosomes: a systematic review

Z Chen, M Xiong, J Tian, D Song, S Duan… - Journal of …, 2024 - Springer
Exosomes are nanoscale extracellular vesicles secreted by cells and enclosed by a lipid
bilayer membrane containing various biologically active cargoes such as proteins, lipids …

The current landscape of glioblastoma biomarkers in body fluids

S Zanganeh, E Abbasgholinejad, M Doroudian… - Cancers, 2023 - mdpi.com
Simple Summary Glioblastoma is a highly aggressive brain cancer, and early detection and
accurate diagnosis are crucial for effective treatment. Traditional diagnostic methods have …

[HTML][HTML] The potential of exosomes as a new therapeutic strategy for glioblastoma

LC Silva, F Branco, J Cunha, C Vitorino… - European Journal of …, 2024 - Elsevier
Glioblastoma (GBM) stands for the most common and aggressive type of brain tumour in
adults. It is highly invasive, which explains its short rate of survival. Little is known about its …

[HTML][HTML] Current non-metal nanoparticle-based therapeutic approaches for glioblastoma treatment

AM Gawel, A Betkowska, E Gajda, M Godlewska… - Biomedicines, 2024 - mdpi.com
The increase in the variety of nano-based tools offers new possibilities to approach the
therapy of poorly treatable tumors, which includes glioblastoma multiforme (GBM; a primary …

Unveiling novel avenues in mtor-targeted therapeutics: Advancements in glioblastoma treatment

S Singh, D Barik, K Lawrie, I Mohapatra… - International journal of …, 2023 - mdpi.com
The mTOR signaling pathway plays a pivotal and intricate role in the pathogenesis of
glioblastoma, driving tumorigenesis and proliferation. Mutations or deletions in the PTEN …

Exosome-Based Macromolecular neurotherapeutic drug delivery approaches in overcoming the Blood-Brain barrier for treating brain disorders

K Yadav, R Vijayalakshmi, KK Sahu, P Sure… - European Journal of …, 2024 - Elsevier
Delivering drugs to the brain is a complex challenge in medical research, particularly for
disorders like Alzheimer's and Parkinson's. The blood–brain barrier restricts the entry of …

Advancements in nanotheranostics for glioma therapy

L Sahoo, SK Paikray, NS Tripathy, D Fernandes… - Naunyn-Schmiedeberg's …, 2024 - Springer
Gliomas are brain tumors mainly derived from glial cells that are difficult to treat and cause
high mortality. Radiation, chemotherapy, and surgical excision are the conventional …

Co-delivery of temozolomide and quercetin with folic acid-conjugated exosomes in glioblastoma treatment

P Pourmasoumi, M Abdouss, M Farhadi… - …, 2024 - Taylor & Francis
Aim: The study aims to improve glioblastoma multiforme (GBM) treatment by combining
temozolomide (TMZ) and quercetin (Qct), using folic acid (FA)-conjugated exosomes to …